Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

Identifying these factors can help open the door to treatment and prevention options. Multiple sclerosis (MS) is a disease of the central nervous system. More than 2.8 million people worldwide ...

Switching therapies is a common part of multiple sclerosis management and may be considered for several reasons.

Multiple sclerosis (MS) is an autoimmune neurological ... Just as the two conditions are different, treatment options for the two conditions differ. There are a variety of different types of ...

Relapsing-remitting multiple sclerosis is an unpredictable disease marked by relapses and remissions, but there are options to help you.

Multiple sclerosis (MS) is a progressive autoimmune disease that affects the brain and spinal cord, impacting 2.8 million ...

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...

Multiple Sclerosis (MS) is a chronic autoimmune ... which can significantly impact disease management. Treatment options for MS generally focus on reducing inflammation, managing symptoms, and ...

Background: Multiple sclerosis is a chronic inflammatory disease of the central nervous system with a pronounced neurodegenerative component. It has been suggested that novel treatment options are ...

Ozanimod▼ is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS) with active ...

A new study revealed safe MS treatment options during pregnancy, reassuring women to balance effective care with their plans ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.